Modification to Purchase Order HHSN271200900448P for High Throughput Copy Number Analysis on 1 x 1M arrarys

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. National Institute on Drug Abuse, Office of Acquisitions- Neurosciences, Station Support/Simplified Acquisitions on behalf of the National Institute on Mental Health (NIMH) intends to negotiate on a sole source basis with the Oxford Gene Technology, Begbroke Science Park, Sandy Lane, Yarnton, Oxford, United Kingdom for a modification to a current purchase order, HHSN271200900448P. Additional quantities, up to 800, of high throughput copy number analysis on Agilent catalogue, 1x1Million arrays using dual color. Oxford Gene Technology is the only known source to provide such arrays and will not cause significant delays in the ongoing protocols and studies. The anticipated period of performance is 12 months. The acquisition is being conducted under simplified acquisition using FAR 12 procedures and is exempt from the requirements of FAR Part 6, Competition Requirement. This notice of intent is not a request for competitive proposals. Interested parties may identify their interest and capabilities in response to this synopsis. The determination by the Government not to compete the proposed contract based upon responses to this notice is solely with the discretion of the Government. Comments to this announcement, referencing synopsis number NOI1178266 may be submitted to the NIDA, Station Support/Simplified Acquisition Branch, 31 Center Drive, Bldg 31, Room 1B59, Bethesda, MD 20892-2080, and Attention: Kathleen Gregory, Contract Specialist.